340B and Pharmaceutical Access

340B and Pharmaceutical Access

The 340B Drug Pricing Program supports safety net providers, such as children's hospitals, in their mission to serve low-income, uninsured and under-insured patients.

340B Helps Kids

This resource provides information and statistics on the 340B program.

CHA Submits Comments for Energy and Commerce Discussion Draft on Drug Shortages

CHA submitted a comment letter to the Energy and Commerce Committee to highlight pediatric needs when addressing drug shortages.

Oct. 23, 2023

CHA Responds to Drug Shortages Request for Information

CHA submitted a response to the bicameral drug shortages request for information (RFI) to highlight pediatric health care needs.

Oct. 19, 2023

CHA Responds to Senate 340B Request for Information

The 340B program supports children’s hospitals in their mission to serve low-income and underinsured children regardless of their insurance status.

Oct. 19, 2023

CHA Submits Comments on 340B Proposed Rule

Children’s Hospital Association sent a comment letter to the Centers for Medicare and Medicaid Services on the 340B remedy proposed rule.

Oct. 16, 2023

CHA Submits Comments on FDA Drug Shortage Guidance

Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.

Oct. 13, 2023

CHA Submits Statement for the Record for Drug Shortages Hearing

Children's Hospital Association submitted a statement for a legislative hearing to highlight children’s needs when strengthening the pediatric drug supply chain.

Sep. 14, 2023

CHA Submits Drug Shortages Hearing Statement for the Record

CHA submitted a statement for a House Energy and Commerce hearing to highlight how children’s needs must be prioritized when strengthening the pediatric drug supply chain.

May 12, 2023

Fiscal Year 2023 Omnibus Summary

This detailed summary of the FY 2023 Omnibus focuses on those provisions of most interest to children’s hospitals.

Jan. 13, 2023

VALID Act Letter

We sent a letter to Senate HELP Committee leadership to highlight the implications of the VALID Act.

June 15, 2022

Contact Us

For more information, connect with us.

(202) 753-5333

For the Record

View CHA communications to federal policymakers such as statements for the record, RFI responses, regulatory comment letters and more.